Metabolic encephalopathy
ICD-10 G93.41 is a billable code used to indicate a diagnosis of metabolic encephalopathy.
Metabolic encephalopathy is a diffuse brain dysfunction caused by a metabolic disturbance, which can result from various systemic conditions such as liver failure, renal failure, infections, or electrolyte imbalances. Patients may present with altered mental status, confusion, seizures, and neurological deficits. The condition is characterized by a rapid onset of symptoms, often reversible if the underlying metabolic issue is identified and treated promptly. Common causes include hepatic encephalopathy due to liver cirrhosis, uremic encephalopathy from renal failure, and hypoglycemic encephalopathy from severe low blood sugar levels. Diagnosis typically involves a thorough clinical evaluation, laboratory tests to identify metabolic derangements, and neuroimaging to rule out structural brain lesions. Treatment focuses on correcting the underlying metabolic disorder, which may involve medications, dietary changes, or dialysis in cases of renal failure. Understanding the multifactorial nature of metabolic encephalopathy is crucial for effective management and coding.
Detailed neurological examination findings, metabolic panel results, and imaging studies.
Patients presenting with confusion, altered mental status, or seizures with known metabolic disorders.
Ensure documentation reflects the acute nature and reversibility of the condition.
Comprehensive history of metabolic conditions, lab results, and treatment plans.
Management of patients with chronic conditions leading to acute metabolic changes.
Document the interdisciplinary approach to managing the underlying metabolic disorder.
Used for follow-up visits for patients diagnosed with metabolic encephalopathy.
Document the patient's history, examination findings, and treatment plan.
Ensure that the visit reflects the complexity of managing metabolic disorders.
Common causes include liver failure, renal failure, severe infections, electrolyte imbalances, and hypoglycemia. Each of these conditions can lead to alterations in brain function and require prompt identification and treatment.
Differentiation is based on the underlying cause. Metabolic encephalopathy is specifically linked to systemic metabolic disturbances, while other types may be due to toxins, infections, or structural brain lesions.
